Effects of bone morphogenic proteins on neural precursor cells and regulation during central nervous system injury

NeuroSignals

Volumn 17, Issue 4, 2009, Pages 255-264

  Sabo, Jennifer K ^a   Kilpatrick, Trevor J ^a   Cate, Holly S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Astrocyte; Bone morphogenic protein; Central nervous system; Neural precursor cell; Oligodendrocyte

Indexed keywords

BONE MORPHOGENETIC PROTEIN;

ASTROCYTE; BRAIN INJURY; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; HUMAN; MICROENVIRONMENT; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PERINATAL PERIOD; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CENTRAL NERVOUS SYSTEM; HUMANS; MODELS, NEUROLOGICAL; NEUROGENESIS; NEURONS; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 70350763859     PISSN: 1424862X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000231892     Document Type: Review

References (67)

1. Tsumaki N, Yoshikawa H: The role of bone morphogenetic proteins in endochondral bone formation. Cytokine Growth Factor Rev 2005; 16: 279-285.
2. Liu A, Niswander LA: Bone morphogenetic protein signalling and vertebrate nervous system development. Nat Rev Neurosci 2005; 6: 945-954.
3. Mehler MF, Mabie PC, Zhang D, Kessler JA: Bone morphogenetic proteins in the nervous system. Trends Neurosci 1997; 20: 309-317.
4. Chen HL, Panchision DM: Concise review: bone morphogenetic protein pleiotropism in neural stem cells and their derivatives -alternative pathways, convergent signals. Stem Cells 2007; 25: 63-68.
5. Kingsley DM: The TGF--superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994; 8: 133-146.
6. Xiao YT, Xiang LX, Shao JZ: Bone morphogenetic protein. Biochem Biophys Res Commun 2007; 362: 550-553.
7. Massague J: TGF--signal transduction. Annu Rev Biochem 1998; 67: 753-791.
8. Itoh S, Itoh F, Goumans MJ, Ten Dijke P: Signaling of transforming growth factor-family members through Smad proteins. Eur J Biochem 2000; 267: 6954-6967.
9. Nakashima K, Yanagisawa M, Arakawa H, Kimura N, Hisatsune T, Kawabata M, Miyazono K, Taga T: Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science 1999; 284: 479-482.
10. Rajan P, Panchision DM, Newell LF, McKay RD: BMPs signal alternately through a SMAD or FRAP-STAT pathway to regulate fate choice in CNS stem cells. J Cell Biol 2003; 161: 911-921.
11. Balemans W, Van Hul W: Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 2002; 250: 231-250.
12. Zimmerman LB, De Jesus-Escobar JM, Harland RM: The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 1996; 86: 599-606.
13. Hata A, Lagna G, Massague J, Hemmati-Brivanlou A: Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 1998; 12: 186-197.
14. Zhu H, Kavsak P, Abdollah S, Wrana JL, Thomsen GH: A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 1999; 400: 687-693.
15. Moren A, Imamura T, Miyazono K, Heldin CH, Moustakas A: Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. J Biol Chem 2005; 280: 22115-22123.
16. Murakami G, Watabe T, Takaoka K, Miyazono K, Imamura T: Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol Biol Cell 2003; 14: 2809-2817.
17. Zhang D, Mehler MF, Song Q, Kessler JA: Development of bone morphogenetic protein receptors in the nervous system and possible roles in regulating trkC expression. J Neurosci 1998; 18: 3314-3326.
18. Mabie PC, Mehler MF, Kessler JA: Multiple roles of bone morphogenetic protein signaling in the regulation of cortical cell number and phenotype. J Neurosci 1999; 19: 7077-7088.
19. Gross RE, Mehler MF, Mabie PC, Zang Z, Santschi L, Kessler JA: Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells. Neuron 1996; 17: 595-606.
20. Miller RH, Dinsio K, Wang R, Geertman R, Maier CE, Hall AK: Patterning of spinal cord oligodendrocyte development by dorsally derived BMP4. J Neurosci Res 2004; 76: 9-19.
21. Lim DA, Tramontin AD, Trevejo JM, Herrera DG, Garcia-Verdugo JM, Alvarez-Buylla A: Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron 2000; 28: 713-726.
22. Colak D, Mori T, Brill MS, Pfeifer A, Falk S, Deng C, Monteiro R, Mummery C, Sommer L, Gotz M: Adult neurogenesis requires Smad4-mediated bone morphogenic protein signaling in stem cells. J Neurosci 2008; 28: 434-446.
23. Doetsch F, Garcia-Verdugo JM, Alvarez-Buylla A: Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain. J Neurosci 1997; 17: 5046-5061.
24. Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylla A: Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999; 97: 703-716.
25. Lois C, Alvarez-Buylla A: Long-distance neuronal migration in the adult mammalian brain. Science 1994; 264: 1145-1148.
26. Doetsch F, Alvarez-Buylla A: Network of tangential pathways for neuronal migration in adult mammalian brain. Proc Natl Acad Sci USA 1996; 93: 14895-14900.
27. Nakashima K, Takizawa T, Ochiai W, Yanagisawa M, Hisatsune T, Nakafuku M, Miyazono K, Kishimoto T, Kageyama R, Taga T: BMP2-mediated alteration in the developmental pathway of fetal mouse brain cells from neurogenesis to astrocytogenesis. Proc Natl Acad Sci USA 2001; 98: 5868-5873.
28. Mathieu C, Sii-Felice K, Fouchet P, Etienne O, Haton C, Mabondzo A, Boussin FD, Mouthon MA: Endothelial cell-derived bone morphogenetic proteins control proliferation of neural stem/progenitor cells. Mol Cell Neurosci 2008; 38: 569-577.
29. Bonaguidi MA, McGuire T, Hu M, Kan L, Samanta J, Kessler JA: LIF and BMP signaling generate separate and discrete types of GFAP-expressing cells. Development 2005; 132: 5503-5514.
30. Kasai M, Satoh K, Akiyama T: Wnt signaling regulates the sequential onset of neurogenesis and gliogenesis via induction of BMPs. Genes Cells 2005; 10: 777-783.
31. Samanta J, Kessler JA: Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development 2004; 131: 4131-4142.
32. Hollnagel A, Oehlmann V, Heymer J, Ruther U, Nordheim A: Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem 1999; 274: 19838-19845.
33. Ying QL, Nichols J, Chambers I, Smith A: BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 2003; 115: 281-292.
34. Pringle NP, Richardson WD: A singularity of PDGF alpha-receptor expression in the dorsoventral axis of the neural tube may define the origin of the oligodendrocyte lineage. Development 1993; 117: 525-533.
35. Soula C, Danesin C, Kan P, Grob M, Poncet C, Cochard P: Distinct sites of origin of oligodendrocytes and somatic motoneurons in the chick spinal cord: oligodendrocytes arise from Nkx2.2-expressing progenitors by a Shh-dependent mechanism. Development 2001; 128: 1369-1379.
36. Mekki-Dauriac S, Agius E, Kan P, Cochard P: Bone morphogenetic proteins negatively control oligodendrocyte precursor specification in the chick spinal cord. Development 2002; 129: 5117-5130.
37. Weible MW 2nd, Chan-Ling T: Phenotypic characterization of neural stem cells from human fetal spinal cord: synergistic effect of LIF and BMP4 to generate astrocytes. Glia 2007; 55: 1156-1168.
38. Samanta J, Burke GM, McGuire T, Pisarek AJ, Mukhopadhyay A, Mishina Y, Kessler JA: Bmpr1a signaling determines numbers of oligodendrocytes and calbindin-expressing interneurons in the cortex. J Neurosci 2007; 27: 7397-7407.
39. Gomes WA, Mehler MF, Kessler JA: Transgenic overexpression of BMP4 increases astroglial and decreases oligodendroglial lineage commitment. Dev Biol 2003; 255: 164-177.
40. Grinspan JB, Edell E, Carpio DF, Beesley JS, Lavy L, Pleasure D, Golden JA: Stage-specific effects of bone morphogenetic proteins on the oligodendrocyte lineage. J Neurobiol 2000; 43: 1-17.
41. Grinspan JB, Stern JL, Pustilnik SM, Pleasure D: Cerebral white matter contains PDGF-responsive precursors to O2A cells. J Neurosci 1990; 10: 1866-1873.
42. Raff MC, Miller RH, Noble M: A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 1983; 303: 390-396.
43. Raff MC: Glial cell diversification in the rat optic nerve. Science 1989; 243: 1450-1455.
44. Mabie PC, Mehler MF, Marmur R, Papavasiliou A, Song Q, Kessler JA: Bone morphogenetic proteins induce astroglial differentiation of oligodendroglial- astroglial progenitor cells. J Neurosci 1997; 17: 4112-4120. (Pubitemid 27220602)
45. Kondo T, Raff M: Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science 2000; 289: 1754-1757.
46. Kondo T, Raff MC: A role for noggin in the development of oligodendrocyte precursor cells. Dev Biol 2004; 267: 242-251.
47. Sim FJ, Lang JK, Waldau B, Roy NS, Schwartz TE, Pilcher WH, Chandross KJ, Natesan S, Merrill JE, Goldman SA: Complementary patterns of gene expression by human oligodendrocyte progenitors and their environment predict determinants of progenitor maintenance and differentiation. Ann Neurol 2006; 59: 763-779.
48. Woodruff RH, Tekki-Kessaris N, Stiles CD, Rowitch DH, Richardson WD: Oligodendrocyte development in the spinal cord and telencephalon: common themes and new perspectives. Int J Dev Neurosci 2001; 19: 379-385.
49. Scherer SS, Braun PE, Grinspan J, Collarini E, Wang DY, Kamholz J: Differential regulation of the 2,3 -cyclic nucleotide 3 phosphodiesterase gene during oligodendrocyte development. Neuron 1994; 12: 1363-1375.
50. Cheng X, Wang Y, He Q, Qiu M, Whittemore SR, Cao Q: Bone morphogenetic protein signaling and Olig1/2 interact to regulate the differentiation and maturation of adult oligodendrocyte precursor cells. Stem Cells 2007; 25: 3204-3214.
51. See J, Zhang X, Eraydin N, Mun SB, Mamontov P, Golden JA, Grinspan JB: Oligodendrocyte maturation is inhibited by bone morphogenetic protein. Mol Cell Neurosci 2004; 26: 481-492.
52. See J, Mamontov P, Ahn K, Wine-Lee L, Crenshaw EB 3rd, Grinspan JB: BMP signaling mutant mice exhibit glial cell maturation defects. Mol Cell Neurosci 2007; 35: 171-182.
53. Bonaguidi MA, Peng CY, McGuire T, Falciglia G, Gobeske KT, Czeisler C, Kessler JA: Noggin expands neural stem cells in the adult hippocampus. J Neurosci 2008; 28: 9194-9204.
54. Mizuguchi R, Sugimori M, Takebayashi H, Kosako H, Nagao M, Yoshida S, Nabeshima Y, Shimamura K, Nakafuku M: Combinatorial roles of Olig2 and Neurogenin2 in the coordinated induction of pan-neuronal and subtype-specific properties of motoneurons. Neuron 2001; 31: 757-771.
55. Zhao C, Fancy SP, Magy L, Urwin JE, Franklin RJ: Stem cells, progenitors and myelin repair. J Anat 2005; 207: 251-258.
56. Fuller ML, DeChant AK, Rothstein B, Caprariello A, Wang R, Hall AK, Miller RH: Bone morphogenetic proteins promote gliosis in demyelinating spinal cord lesions. Ann Neurol 2007; 62: 288-300.
57. Ara J, See J, Mamontov P, Hahn A, Bannerman P, Pleasure D, Grinspan JB: Bone morphogenetic proteins 4, 6, and 7 are up-regulated in mouse spinal cord during experimental autoimmune encephalomyelitis. J Neurosci Res 2008; 86: 125-135.
58. Deininger M, Meyermann R, Schluesener H: Detection of two transforming growth factor-related morphogens, bone morphogenetic proteins-4 and-5, in RNA of multiple sclerosis and Creutzfeldt-Jakob disease lesions. Acta Neuropathol 1995; 90: 76-79.
59. Setoguchi T, Yone K, Matsuoka E, Takenouchi H, Nakashima K, Sakou T, Komiya S, Izumo S: Traumatic injury-induced BMP7 expression in the adult rat spinal cord. Brain Res 2001; 921: 219-225.
60. Setoguchi T, Nakashima K, Takizawa T, Yanagisawa M, Ochiai W, Okabe M, Yone K, Komiya S, Taga T: Treatment of spinal cord injury by transplantation of fetal neural precursor cells engineered to express BMP inhibitor. Exp Neurol 2004; 189: 33-44.
61. Hampton DW, Asher RA, Kondo T, Steeves JD, Ramer MS, Fawcett JW: A potential role for bone morphogenetic protein signalling in glial cell fate determination following adult central nervous system injury in vivo. Eur J Neurosci 2007; 26: 3024-3035.
62. Enzmann GU, Benton RL, Woock JP, Howard RM, Tsoulfas P, Whittemore SR: Consequences of noggin expression by neural stem, glial, and neuronal precursor cells engrafted into the injured spinal cord. Exp Neurol 2005; 195: 293-304.
63. Chang CF, Lin SZ, Chiang YH, Morales M, Chou J, Lein P, Chen HL, Hoffer BJ, Wang Y: Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats. Stroke 2003; 34: 558-564.
64. Liu Y, Belayev L, Zhao W, Busto R, Saul I, Alonso O, Ginsberg MD: The effect of bone morphogenetic protein-7 (BMP-7) on functional recovery, local cerebral glucose utilization and blood flow after transient focal cerebral ischemia in rats. Brain Res 2001; 905: 81-90.
65. Chou J, Harvey BK, Chang CF, Shen H, Morales M, Wang Y: Neuroregenerative effects of BMP7 after stroke in rats. J Neurol Sci 2006; 240: 21-29.
66. Talbott JF, Cao Q, Enzmann GU, Benton RL, Achim V, Cheng XX, Mills MD, Rao MS, Whittemore SR: Schwann cell-like differentiation by adult oligodendrocyte precursor cells following engraftment into the demyelinated spinal cord is BMP-dependent. Glia 2006; 54: 147-159.
67. Zhang Z, Trautmann K, Artelt M, Burnet M, Schluesener HJ: Bone morphogenetic protein-6 is expressed early by activated astrocytes in lesions of rat traumatic brain injury. Neuroscience 2006; 138: 47-53.